This page is currently under construction. For orders, please visit
or return to Aushealth homepage.
Home / Research / Apomab


A ground-breaking cancer treatment and diagnostics tool, developed at the Royal Adelaide Hospital in South Australia.

After years of research at RAH exploring the unique mechanism and potential of APOMAB to diagnose and treat cancer in preclinical models, it is highly pleasing to see this technology demonstrate targeted delivery of radiation to tumours in clinical settings.

Professor Michael Brown

Our early research demonstrated that APOMAB binds cancer cells after cytotoxic anticancer treatment. It’s brilliant to see the same binding effect taking place in APOMAB-dosed cancer patients.

Managing Director and CEO Greg Johansen
Hit enter to search or ESC to close